Summary
This 8-K filing from Oracle Corporation announces a significant definitive agreement to acquire Cerner Corporation through a cash tender offer. Oracle, via its subsidiary OC Acquisition LLC, will offer $95.00 per share for all outstanding shares of Cerner common stock. The transaction, structured as a merger following the tender offer, is a major strategic move for Oracle, likely aimed at expanding its presence in the healthcare technology sector. Key conditions for the transaction include regulatory approvals, such as antitrust clearances (including Hart-Scott-Rodino and EU approvals), and the tender of a majority of Cerner's outstanding shares. The deal is expected to close after these conditions are met, with the merger to follow promptly. Cerner's Board of Directors has unanimously approved the agreement and recommends that shareholders tender their shares.
Key Highlights
- 1Oracle to acquire Cerner Corporation for $95.00 per share in cash.
- 2Transaction structured as a cash tender offer followed by a merger.
- 3The total deal value implies a significant premium for Cerner shareholders.
- 4The acquisition is subject to customary closing conditions, including regulatory approvals (e.g., HSR Act, EU antitrust).
- 5A majority of Cerner's outstanding shares must be tendered for the offer to be successful.
- 6Cerner's Board of Directors has unanimously approved the merger agreement and recommends shareholders tender their shares.
- 7Cerner's executive officers and directors have entered into tender support agreements, collectively holding less than 1% of outstanding shares.